CA3074232C - Composes, compositions et methodes pour le traitement d'une maladie - Google Patents

Composes, compositions et methodes pour le traitement d'une maladie

Info

Publication number
CA3074232C
CA3074232C CA3074232A CA3074232A CA3074232C CA 3074232 C CA3074232 C CA 3074232C CA 3074232 A CA3074232 A CA 3074232A CA 3074232 A CA3074232 A CA 3074232A CA 3074232 C CA3074232 C CA 3074232C
Authority
CA
Canada
Prior art keywords
date
compound
alkyl
received
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3074232A
Other languages
English (en)
Other versions
CA3074232A1 (fr
Inventor
Anjaneyulu Sheri
Geeta Meher
Sreerupa Challa
Shenghua Zhou
Radhakrishnan P. Iyer
Original Assignee
Invox Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invox Pharma Ltd filed Critical Invox Pharma Ltd
Priority claimed from PCT/US2018/048705 external-priority patent/WO2019046511A1/fr
Publication of CA3074232A1 publication Critical patent/CA3074232A1/fr
Application granted granted Critical
Publication of CA3074232C publication Critical patent/CA3074232C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des composés et des compositions pour l'activation ou l'induction de l'expression d'un récepteur de reconnaissance de motifs (par exemple, STING, RIG-I, MDA5), et leurs méthodes d'utilisation.
CA3074232A 2017-08-31 2018-08-30 Composes, compositions et methodes pour le traitement d'une maladie Active CA3074232C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762552473P 2017-08-31 2017-08-31
US62/552,473 2017-08-31
US201862664493P 2018-04-30 2018-04-30
US62/664,493 2018-04-30
PCT/US2018/048705 WO2019046511A1 (fr) 2017-08-31 2018-08-30 Composés, compositions et méthodes pour le traitement d'une maladie

Publications (2)

Publication Number Publication Date
CA3074232A1 CA3074232A1 (fr) 2019-03-07
CA3074232C true CA3074232C (fr) 2026-04-21

Family

ID=

Similar Documents

Publication Publication Date Title
JP7673118B2 (ja) 化合物、組成物、及び疾患の治療方法
JP7749629B2 (ja) 疾患の治療のための化合物、組成物、および方法
US12390668B2 (en) Compounds, compositions, and methods for the treatment of disease
US12187761B2 (en) Compounds, compositions, and methods for the treatment of disease
WO2018009652A1 (fr) Composés, compositions et méthodes de traitement de maladie
WO2018013887A1 (fr) Composés, compositions et méthodes de traitement de maladie
JP2019521138A (ja) 疾患の治療のための化合物、組成物、および方法
WO2017011622A1 (fr) Composés et compositions qui induisent rig-i et d'autres récepteurs de reconnaissance de motifs
WO2019161171A1 (fr) Formulations de nanoparticules d'agonistes de sting
US12291548B2 (en) Compounds, compositions, and methods for the treatment of disease
CA3074232C (fr) Composes, compositions et methodes pour le traitement d'une maladie